Health News Releases

  • Today February 19
November 12, 2013 16:40
Growing Body of Evidence Supports V.A.C. VeraFlo™ Therapy Changing How Clinicians Approach Treating Wounds
Kinetic Concepts, Inc. announced today that new clinical and scientific evidence has emerged supporting the effectiveness of V.A.C. VeraFlo™ Instillation Therapy (NPWTi) compared to traditional V.A.C.
November 12, 2013 14:40
DOW-COLORCON Controlled Release Alliance Launches METHOCEL™ DC2 to Help Reduce Development Time and Lower Manufacturing Costs at The 2013 AAPS Annual Meeting and Expo
Dow Pharma & Food Solutions, a business unit of The Dow Chemical Company (NYSE: DOW) and Colorcon Inc., will present the next-generation METHOCEL™ DC2 polymer at the American Association of Pharmaceut
Inside Osan Seoul Children’s Hospital
November 12, 2013 11:59
Cell-Line Obesity Clinic Osan Branch to Open inside Osan Seoul Children’s Hospital
Cell-Line Obesity Clinic Osan Branch to open On coming November 18th (Mon), Cell-Line Obesity Clinic will open on the third floor of Osan ‘Seoul Children’s Hospital’, the first children’s hospital
November 12, 2013 11:36
EasyMed Implements Its Easy SmartCare Technology in the Cardiology Department of University Hospital Geneva (HUG)
EasyMed Services Inc. (www.EasyMedMobile.com) (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) today announced that the cardiology department of HUG has begun using its Easy SmartCare technology. EasyMed recently
November 11, 2013 14:05
WOUNDCHEK™ Laboratories - Leaders and innovators in wound diagnostics split from Systagenix
WOUNDCHEK™ Laboratories announced today that it has successfully completed the spin out of the diagnostics business from Systagenix and has signed a non-exclusive global distribution agreement with Ki
November 11, 2013 13:35
Saudi Arabia Hosts The Brain Forum
Jeddah, Saudi Arabia will be hosting the first of its kind symposium in the Middle East region that will bring together some of the world’s top inspirational thinkers and pioneers in the field of Brai
November 08, 2013 18:30
Menarini Asia-Pacific Announces Inauguration of Menarini China HQ
Menarini Asia-Pacific, a member of the world’s largest Italian biopharmaceutical company, officially inaugurated the establishment of Menarini (China) Investment Co. Ltd. and the opening of its nation
November 08, 2013 15:26
New data presented at AASD further demonstrate benefits of Trajenta® (linagliptin) with efficacy and safety in specific patient populations
For Non-US and Non-UK Media Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes (T2D) and liv
ENDOCEM MTA
November 08, 2013 13:56
Partial Pulpotomy using Maruchi Product Recognized a New Health Technology by the Ministry of Health - Health Insurance Benefit Expected
On October 10th, the Committee for New Health Technology Assessment passed the final deliberation regarding Clinical safety and effectiveness of partial pulpotomy using Endocem MTA and Endocem ZR by G
November 08, 2013 11:20
3M Files Patent Infringement Lawsuits in Germany to Protect Dental Ceramic Coloring Technology
As part of its ongoing program to license to the dental industry 3M's patented technology that enables the coloring of ceramic-based dental restorations, and to protect its technology against unlicens
(example) This product is G-Cool.
November 08, 2013 10:48
Daeyang Medical’s Electroporation System: G-Cool
Daeyang Medical (CEO Yun Il Yong, www.daeyangmed.com) had introduced in the beginning of February its new product G-Cool, and its sales has been increasing ever since. G-Cool is a non-needle type meso
(Example) Before (left) and after (right) the cellulite treatment using Decell
November 08, 2013 10:46
Daeyang Medical Develops a Beauty Treatment Device Decell
Medical device Decell developed by Daeyang Medical Co., Ltd.(CEO Yun Il Yong, www.daeyangmed.com) uses the shock wave to remove fat and cellulite in order to help building fit body and reduce pain. Al
SPMI-330
November 08, 2013 09:51
Promedi Introduces a Complex Low Frequency Stimulator SPMI-300 for Reducing Muscle Pain
Medical device company Promedi Co.,Ltd. (CEO Jong Cheol Park) said it has acquired the production license for its complex low frequency stimulator SPMI-330 on October 28th. SPMI-330 is a complex m
November 07, 2013 16:50
New survey in four major Asian countries reveals complexity of managing Type 2 Diabetes is currently underestimated1
- For Non-US and Non-UK Media Boehringer Ingelheim and Eli Lilly and Company today announced results from a poll conducted with almost 800 physicians treating people with Type 2 Diabetes (T2D), in
November 04, 2013 17:00
Terumo BCT Acquires GADA Turkey
Terumo BCT has acquired GADA® Turkey, an exclusive supplier and world-class distributor of blood bank components and equipment to Turkish public and private healthcare facilities. GADA Turkey has b
November 04, 2013 16:00
electroCore's clinical trial program into non invasive vagus nerve stimulation therapy gathers momentum
Following the announcement last month that it had fully enrolled its pilot FDA chronic migraine study electroCore has announced that its European randomized controlled trial, GC - 002, for the prevent
motor orthopedic exerciser (CPM, CPS-3000)
November 04, 2013 14:06
Rehabilitation Equipment Maker Promedi Signs the ISO 13485 and CE Mark Certification Agreement for Oversea Expansion
Medical device company Promedi (CEO Jong Cheol Park, www.stratek.co.kr) said it has signed an agreement with the Korea Institute of Medial Device Assessment (KIMDA) for the ISO 13485 and CE mark certi
BT booth at APMSH 2013
November 04, 2013 11:00
Medical Training Simulator Company BT Well Received at APMSH 2013 in China
Medical training simulator company BT Inc. (CEO Yang Seung Jin/Park Yong Ki, www.btinc.co.kr) participated in the Asia-Pacific Meeting on Simulation in Healthcare (APMSH) 2013 in China from October 24
November 04, 2013 09:40
Phase III data show Boehringer Ingelheim's faldaprevir* was highly effective in a broad range of patients with genotype-1 hepatitis C
Boehringer Ingelheim today announced new data from its Phase III clinical trial programme, STARTVerso™, which evaluates faldaprevir* in combination with pegylated interferon and ribavirin (PegIFN/RBV)
Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising Phase II data
November 04, 2013 09:40
Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising Phase II data
Interim data presented today show that all patients (13/13) who reached their 4-week post-treatment follow-up have undetectable levels of hepatitis C virus (SVR4) after completing a 12-week regimen of
DairyGuard™
November 01, 2013 17:10
PerkinElmer’s DairyGuard™ is the First Analyzer to Add Screening for Unknown Adulterants in Milk Powder
PerkinElmer, Inc., a global leader in improving the health and safety of people and the environment, today introduced the DairyGuard™ milk powder analyzer, a near infrared (NIR) spectrometer specifica
November 01, 2013 15:35
Quintiles President & COO John Ratliff to Leave Company at End of 2013
Quintiles today announced that John Ratliff has resigned his position as president and chief operating officer (COO) effective December 31, 2013. He has also resigned his role as a member of the Quint
October 30, 2013 09:09
IncellDx Signs Agreement With Bristol-Myers Squibb Related to the Development of an Assay for a Companion Diagnostic Test
IncellDx, Inc. announced today that they have entered into an agreement with Bristol-Myers Squibb Company (NYSE:BMY) related to the development of an assay for potential application in a molecular com
October 25, 2013 22:00
BBC World News Features Legal Industrial Hemp-Based Cannabidiol (CBD) Product With Cheryl Shuman, Medical Marijuana Inc.'s HempMedsPX Brand Ambassador & Medical Cannabis Advocate, on Friday, October 25th
Medical Marijuana, Inc.(http://medicalmarijuanainc.com/) (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX™(http://hempmedspx.com/)—a corporate portfolio company
NP-1000
October 25, 2013 15:12
N-Care’s Paraffin Bath NP-1000 and NP-1000 Plus for Pain Relief Sells Well In and Outside the Country
The paraffin bath introduced by N-Care (CEO Seung-Beom Han, www.n-care.co.kr) is going well in both domestic and international market, showing a noteworthy sales record. N-Care signed an export agr
25 per page50 per page75 per page100 per page